Psychiatry Malpractice Insurance in New York: A 2026 Physician's Guide

TL;DR. Psychiatry malpractice insurance in New York runs on a different rate scale than the rest of the NY physician market, with statewide base rates at $1M/$3M claims-made limits typically in the ~$13K–$16K annual range, before territory modifiers that push Long Island and Manhattan premiums to the top of a ~$7K–$22K effective span. The APA-endorsed American Professional Agency program, PRMS, MedPro, and CNA write most of the voluntary NY psychiatry book. What drives the rate is not frequency, it is a narrow set of high-severity exposures: suicide, duty-to-warn, medication management, Mental Hygiene Law 9.39 admissions, and the growing telepsychiatry and ketamine-infusion footprint that traditional psychiatric policies were not drafted to cover.

Why psychiatry is a separate malpractice market

Psychiatry sits in its own rating bucket because the claim pattern is structurally different from the rest of medicine. Claim frequency runs roughly in line with, or slightly below, the internal-medicine average, but severity is concentrated in a narrow band of high-stakes allegations: suicide and self-harm, failure to warn identifiable third parties, medication-management adverse events, and Mental Hygiene Law admission decisions. New York's psychiatric base rate of ~$13K–$16K at $1M/$3M claims-made limits sits well below the ~$29K–$32K Internal Medicine base (Morningside Health & Risk 2026 territory benchmark, derived from MLMIC, EmPRO, and TDC rate filings), a pricing gap carriers justify by the absence of procedural severity tails that drive OB/GYN and surgical books.

How the claim pattern differs from the rest of medicine

A psychiatrist's exposure does not come from a procedure gone wrong. It comes from a clinical-judgment decision that a plaintiff's counsel will later argue should have been different: a patient discharged the morning before a suicide attempt, a prescription continued past the point of clinical tolerance, a Tarasoff-style threat documented without a contemporaneous warning to the named third party. Each of these scenarios carries a reconstructable paper trail, which is why contemporaneous documentation matters more in psychiatry than in almost any other specialty.

The severity distribution is bimodal. Most paid psychiatric claims settle in the low six figures. A small share, the high-severity cases involving completed suicide in an inpatient setting or a third-party harm traced back to a failure-to-warn allegation, resolve at seven and occasionally eight figures. Carriers reserve against the tail of that distribution, and the statewide base rate reflects the reserve math more than the typical claim cost.

Why NY psychiatry still prices below national averages

New York's ~$13K–$16K psychiatric base is lower than the physician comparison in this state would suggest because the no-damage-caps regime that drives NY surgical and OB premium has less traction on psychiatric severity. Jury verdicts on pure economic-loss and pain-and-suffering components for a suicide case are moderated by comparative-negligence findings in a way that an infant-injury OB verdict is not. The sibling medical malpractice insurance guide for New York walks through how CPLR 214-a and Lavern's Law apply across the full physician book, and why psychiatry's 2½-year limitation window creates a meaningfully shorter reserve tail than Pediatrics or OB/GYN.

The flip side, for the handful of NY psychiatrists practicing on Long Island or in Nassau County, is that territory factors still apply. A downstate psychiatric book can run 30–50% above the statewide base even though the specialty sits in the lowest tier of physician rating classes.

NY cost table

Statewide 2026 base rates for NY psychiatry at $1M/$3M claims-made limits run ~$13K–$16K annually before territory modifiers, with tail at approximately 150–200% of the most recent annual premium. Territory factors push the effective range to roughly ~$7K–$22K depending on practice location, with Rochester and the Southern Tier at the low end and Nassau or Suffolk county at the top. Specialty scope items, particularly inpatient admitting privileges, ECT, ketamine, and forensic work, layer additional relativities on top of the base.

Statewide base rate and territory effective range

Why the psychiatry table looks flatter than surgical tables

The territory spread in psychiatry is narrower than in surgical specialties because the downstate verdict premium attaches most aggressively to bodily-injury severity. A psychiatric case involving medication-induced injury or completed suicide draws on a different juror calculus than an intraoperative injury. Carriers still apply downstate territory modifiers, but the factor compresses compared to the 3–5× spread seen on OB/GYN and Orthopedic Surgery books described in the sibling pillar Guide.

Tail at 150–200% of the most recent annual premium remains the industry rule, and our sibling Insight on when tail coverage is required and how to price it walks through the multiplier in detail. For a Manhattan psychiatrist at the top of the territory band, that tail is a mid-to-high-five-figure one-time check at retirement, job change, or specialty shift. It is not the career-defining bill an OB/GYN writes, but it is not trivial either.

Carriers for NY psychiatrists

Four carriers underwrite the bulk of the voluntary NY psychiatry book. The APA-endorsed American Professional Agency program is the historical default for NY psychiatrists through American Psychiatric Association affiliation, with competitive base pricing and an established claims-handling reputation. PRMS writes psychiatry nationally with a managing-general-agent relationship to Fair American Insurance and Reinsurance Company, and is often the first alternative brokers show. MedPro Group, a Berkshire Hathaway subsidiary, and CNA round out the serious quote list. MLMIC will write psychiatry within its broader NY physician book but is not a psychiatry-specialist carrier.

APA-endorsed American Professional Agency

American Professional Agency carries the American Psychiatric Association endorsement and has been the default NY psychiatric program for decades. APA endorsement matters for three reasons beyond price. The program was drafted against the psychiatric-specialty exposure pattern, rather than reverse-engineered from a general physician form. The claims team is psychiatry-experienced, which affects settlement posture on reputationally sensitive cases such as duty-to-warn and boundary allegations. And the risk-management resources, including member-facing ethics and practice guidance, are integrated with APA's professional infrastructure.

Pricing typically sits at or just below the statewide benchmark for outpatient solo psychiatrists with clean claims histories. Group-practice pricing and child-and-adolescent relativities are competitive, though not always the lowest number in a multi-carrier quote set.

PRMS, MedPro, and CNA as alternatives

PRMS, the Professional Risk Management Services program underwritten through Fair American, is the largest dedicated psychiatric alternative to the APA-endorsed program. PRMS competes primarily on service posture, telepsych endorsement breadth, and a well-documented risk-management program rather than on headline price. For psychiatrists who practice across multiple states or who want a dedicated psychiatric claims team without the APA membership tie-in, PRMS is frequently the cleaner placement.

MedPro and CNA both write psychiatry inside broader national physician books. MedPro's appetite is strong on employed-physician placements and hospital-affiliated groups where the carrier can consolidate the full credentialing schedule. CNA writes NY psychiatry selectively, typically on larger group accounts where the broker is already placing general liability or property through the same relationship.

When MLMIC, EmPRO, or TDC make sense

For NY psychiatrists practicing inside multi-specialty physician groups insured by MLMIC, EmPRO, or The Doctors Company, rolling into the group's existing carrier often makes administrative sense even if a dedicated psychiatric carrier would underwrite the individual book at a slightly lower price. Continuity of retro date, shared defense counsel across the group, and hospital credentialing alignment can outweigh a small premium delta. The sibling pillar Guide's coverage basics section on claims-made versus occurrence covers the retro-date mechanics that matter most on a switch.

Telepsychiatry across state lines

Telepsychiatry coverage turns on a single threshold question: was the psychiatrist licensed in the patient's state at the time of the session. New York carriers read telepsych sessions as occurring where the patient sits, not where the psychiatrist sits. A New York psychiatrist running a Thursday-afternoon video visit with a patient physically in Florida is practicing in Florida for licensure purposes, and the malpractice policy follows that fact. New York has not joined the Interstate Medical Licensure Compact, so NY psychiatrists do not get IMLC reciprocity for out-of-state patients, and the carrier will want a separate license or recognized registration on file for each state.

Why NY's absence from the IMLC matters

The Interstate Medical Licensure Compact provides an expedited licensure pathway for physicians practicing across compact-member states. New York is among the handful of states that have not joined, which means a NY psychiatrist who wants to see a student who has relocated to Pennsylvania or a retired parent who has moved to Florida must pursue full licensure in those states through each state's ordinary pathway, not the compact. Carriers will ask for a license number per state and will typically schedule each state on the declarations page or require a telepsych endorsement that names the practice states.

For psychiatrists with a snowbird caseload or a college-aged patient panel with out-of-state summer breaks, this creates a real operational burden. The alternative, declining telepsych while the patient is out of state, is the safer malpractice answer but disruptive to continuity of care. The sibling Insight on therapist malpractice insurance in New York covers how the parallel mental-health compacts (PSYPACT for psychologists, the Social Work Licensure Compact for LCSWs) are reshaping the allied-health telehealth picture, while psychiatry remains tied to state-by-state medical licensure.

Practical underwriting checkpoints

Three practical rules reduce telepsych coverage exposure. Confirm with the carrier in writing which states are scheduled for telepsychiatry before the first session in each new state. Document the patient's physical location at the start of each session in the clinical note, not just the initial intake. If a patient relocates mid-treatment, re-confirm both licensure and coverage before the next session, not at the next policy renewal. A psychiatrist who discovers a licensure gap at renewal has already had the gap for months of treatment, and the carrier's defense posture on a claim from that window will reflect the gap.

Ketamine infusion and TMS riders

Ketamine-assisted treatment and transcranial magnetic stimulation are the two fastest-growing scope additions in NY psychiatric practice, and both sit uncomfortably on a standard psychiatric policy form. Ketamine in particular was not contemplated by the policy language most NY psychiatrists carry, which was drafted around medication management and psychotherapy without a procedural component. Carriers have responded with endorsements, but the endorsement menu varies meaningfully across APA-endorsed, PRMS, MedPro, and CNA.

Why ketamine infusion changes the rating class

IV ketamine infusion, whether billed as a Spravato-adjacent treatment or as an off-label infusion protocol, introduces a procedural severity exposure that pure psychotherapy and prescription management do not carry. The carrier's underwriting question set shifts: credentialing and training in infusion therapy, monitoring protocol during and after administration, emergency equipment on site, informed consent specific to off-label use, and patient selection criteria. Some carriers will endorse the procedure at the psychiatric base rate with a small relativity. Others move the physician into a mixed medical-psychiatric class that adds 20–40% to the annual premium.

Intranasal esketamine (Spravato) administered in a REMS-certified setting is typically a cleaner coverage question because the FDA-approved indication, dosing, and monitoring protocol are defined. Off-label IV ketamine administered for depression or PTSD, particularly at higher doses or in a clinic structured as a standalone infusion center rather than a psychiatry practice, draws more underwriting scrutiny and occasionally a declination. A written carrier acknowledgment of the specific protocol, not a general "we cover psychiatry" assurance, is the defensible baseline.

TMS as the cleaner endorsement

TMS is generally a simpler coverage conversation. The procedure has an established FDA-cleared device footprint, a well-documented adverse-event profile dominated by transient headache and scalp discomfort rather than severe injury, and a supervision model that fits psychiatric practice patterns. Most NY carriers will endorse TMS at or very near the psychiatric base rate after confirming the device, the supervising psychiatrist's training, and the patient screening protocol.

The exposure that does matter on TMS is seizure. Treatment-emergent seizure is a documented low-frequency adverse event, and the policy response turns on whether the procedure was administered within the device labeling, by appropriately credentialed staff, with the contraindication screening that the labeling requires. Policies that endorse TMS at the psychiatric base rate do so on the assumption that those controls are in place.

NY Mental Hygiene Law 9.39 exposure

Mental Hygiene Law 9.39 authorizes emergency involuntary admission of a person alleged to have a mental illness likely to result in serious harm to self or others, for up to 15 days of evaluation. The statute grants qualifying psychiatrists admitting authority at designated hospitals and creates a bidirectional malpractice exposure: failure to admit when the clinical standard supports it, and wrongful detention when it does not. Mental Hygiene Law 9.39 claims are concentrated in a small number of NY psychiatrists by volume, but the severity on both sides, wrongful-death from a missed 9.39 admission and civil-rights allegations from a contested admission, can run well into the seven figures.

The two-directional risk

Psychiatrists who admit patients under 9.39 carry documentation exposure on the admission side. The statute requires contemporaneous documentation of the likelihood of serious harm, the basis for that determination, and the reason alternatives to admission were inadequate. A chart that reads "patient appeared agitated, admitted under 9.39" is insufficient. A chart that reconstructs the specific factual observations, collateral information, and the weighing of less-restrictive alternatives is defensible.

The failure-to-admit side is the mirror image. A psychiatrist who evaluates a patient in the emergency department, declines to admit under 9.39, and releases the patient who then completes a suicide has created a contemporaneous record that plaintiff's counsel will read against the statute. The defensible posture is a documented application of the 9.39 standard to the specific presentation, not a conclusory note.

Why carriers watch 9.39 volume at renewal

Underwriters ask about 9.39 admission volume at application and renewal because it correlates with the two highest-severity psychiatric allegation patterns. A psychiatrist staffing an emergency department or a designated inpatient admitting unit will typically see both a higher annual premium and a tighter claims-handling posture than an outpatient-only psychiatrist with no admitting privileges. This is one reason the cost table above breaks out "Manhattan, inpatient admitting privileges" as a separate row.

Suicide and self-harm claims

Completed suicide and serious self-harm allegations are the single highest-severity psychiatric claim pattern. The allegation structure typically follows one of three templates: failure to assess for suicide risk on a visit where the risk was present, failure to admit or escalate care when the assessment supported it, or inadequate discharge planning from an inpatient or partial-hospitalization setting. Each template has a known defense posture, and each turns on the contemporaneous record.

The three common allegation templates

The missed-assessment template argues that the psychiatrist did not perform, or did not document, a risk assessment that the standard of care required on the visit in question. The failure-to-escalate template accepts the assessment but alleges that the clinical response, continuing outpatient care, adjusting medication, scheduling a next visit, was inadequate given the level of risk. The inadequate-discharge template applies to inpatient and partial-hospital settings and alleges that the treatment plan, support structure, or follow-up on discharge was insufficient for the acuity the patient presented on the final day of the index admission.

All three templates turn on the record. A standardized suicide risk assessment completed and documented on the visit, a documented clinical rationale for the chosen level of care, and a documented discharge plan with specific follow-up timing, contact information, and warning-sign counseling are the three most useful controls a NY psychiatrist can maintain. None requires new technology. All three require a commitment to contemporaneous documentation under time pressure.

Why the reserve math compounds

Psychiatric claims develop slower than procedural claims. An allegation of inadequate suicide assessment can surface months or years after the patient encounter, and the reserve math compounds with the statute-of-limitations window under CPLR 214-a, 2 years and 6 months from the alleged act or the end of continuous treatment. Continuous-treatment doctrine matters here: a patient in a years-long course of psychiatric care does not start the limitation clock until treatment ends, so a single course of outpatient psychiatry can generate a reporting window that extends well past the typical tail period. The sibling Insight on occurrence versus claims-made malpractice insurance in New York covers how the two policy structures respond to delayed-report claims, which matter disproportionately in psychiatry.

Scope differences: psychiatrist vs NP vs LCSW

New York licenses mental-health practitioners under separate statutory articles, and the scope differences drive what each policy form actually covers. A psychiatrist licensed as an MD or DO under Education Law Article 131 practices the full medical scope, including prescribing, ECT, and admission authority under Mental Hygiene Law 9.39. A psychiatric nurse practitioner licensed under Article 139 carries prescribing authority but not 9.39 admitting authority. An LCSW or LMHC carries no prescribing authority and a narrower scope again. Malpractice policies track the underlying license, and a practice that blends these license types needs a policy form that names each practitioner's scope correctly.

Practical coverage consequences

A psychiatrist who supervises a psychiatric NP inside a group practice carries vicarious exposure, not direct individual exposure, through the supervision relationship. The NP carries her own professional liability in addition. A group policy that names only the entity and the physicians, without scheduling the NPs as named insureds, creates a coverage-dispute opening the first time an NP's note drives an allegation.

The sibling Insight on therapist malpractice insurance in New York walks through the LCSW, psychologist, and LMHC programs in detail, including MHCA, CPH, and the Trust. For a psychiatric practice that employs or supervises non-physician clinicians, reading that piece alongside this one is how we would recommend mapping the full coverage stack. The sibling pillar Guide on dental malpractice insurance in New York covers many of the same state-licensed, non-procedural-severity scope mechanics that a NY psychiatric group employing mixed license types will recognize. The physicians industry page covers the physician-employer dimension for practices structured with both MDs and allied-health staff.

Tail economics for retiring psychiatrists

Tail coverage, technically an extended reporting endorsement, typically costs 150–200% of the most recent annual claims-made premium, paid as a single lump sum at policy termination. For a Manhattan psychiatrist at ~$17K annual premium, that is a roughly $25K–$34K one-time check at retirement, job change, or specialty shift. The multiplier exists because the carrier must reserve for the long-tail reporting window with no future premium stream. In psychiatry, that window matters more than the headline dollar figure suggests.

Why psychiatric tail is strategically important

Psychiatric allegations surface on a longer timeline than most procedural allegations. Medication-management and suicide-assessment claims frequently report 18 to 36 months after the patient encounter, and continuous-treatment doctrine can extend the limitation window past the end of the active policy. A psychiatrist retiring after a 30-year NY practice who elects to skip tail is self-insuring a reporting window that can run several years past the final day of practice. The math rarely favors that choice.

Free-tail provisions are becoming more common in NY psychiatric employment agreements. The typical trigger is retirement at age 55 or older with at least five years of continuous coverage, total permanent disability, or death. Psychiatrists negotiating a new employment contract should push for a free-tail provision with those triggers at minimum, because retirement and disability are the two termination modes hardest to predict and most expensive to self-fund.

Strategic timing and scope wind-down

Because tail is priced off the most recent annual premium, a psychiatrist approaching retirement can reduce the bill by winding down higher-relativity scope items in the final year. Dropping inpatient admitting privileges, ECT, or ketamine infusion a full policy year before retirement can reduce both the final annual premium and the tail it drives. For a downstate psychiatrist carrying a ketamine endorsement, the savings across the final premium year plus tail can run into the low five figures.

For the broader retirement-planning view, the professional liability service page covers the underwriting view of how NY psychiatric carriers structure tail, free-tail, and nose coverage on carrier switches. A 30-minute conversation with a broker appointed across the APA-endorsed program, PRMS, MedPro, and CNA, 90 days before a renewal or career transition, is typically the most valuable hour in the process. You can request a quote or schedule a consultation when you are ready.